AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
41 hedge funds and large institutions have $12.5M invested in AVEO Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
59% less call options, than puts
Call options by funds: $13K | Put options by funds: $32K
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
41
Holding in Top 10
1
Calls
$13K
Puts
$32K
Top Buyers
| 1 | +$112K | |
| 2 | +$109K | |
| 3 | +$30.1K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.5K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$4.89K |
Top Sellers
| 1 | -$160K | |
| 2 | -$87K | |
| 3 | -$70.4K | |
| 4 |
Morgan Stanley
New York
|
-$36.1K |
| 5 |
Goldman Sachs
New York
|
-$24K |